Our CEO Immanuel Lerner will be attending & presenting at the NextGen Biomed 2025 in London, March 12-13
Join our CEO, Immanuel Lerner for insights on AI-driven peptide drug discovery:📅 March 12:🗝 Keynote – Orally Available Peptides | 9:55 AM💡 Panel – Novel Peptide Therapeutics | 12:30 PM 📅 March 13:🎙 Moderator – Optimizing Drug Candidates | 2:15 PM
Our CEO and co-founder, Dr. Immanuel Lerner and our Advisory Board Member, Dr. Sarah Benson-Konforty will attend the J.P. Morgan Global Healthcare Conference
Join them at the J.P. Morgan 43rd Annual Healthcare Conference 2025, which will take place 13-16 January 2025 in San Francisco, CA, USA.Mr. Lerner will also participate in the Executive Roundtable Wuxi Global Forum, and host a table on Jan 14th from 5-6pm PST. You can reserve a spot here >> https://lnkd.in/d6qhfYWi
Our CEO Immanuel Lerner will be presenting at the DDIF 15th Annual Drug Discovery Innovation Forum in Berlin on September 5th
Our CEO Immanuel Lerner has been selected to speak at the #DDIF 15th Annual Drug Discovery Innovation Forum in Berlin, on September 4-5, 2024!
Our COO Maayan Elias Robicsek will attend Biomed Israel 2025, May 21-23/2024
Our COO Maayan Elias Robicsek is attending Biomed Israel 2025! Come and say hello to learn about our AI drug discovery platform
Visit us at BIOMED Israel May 16-18
Join us at booth #3 in the Start-Up Pavilion on May 16th, at BIOMED 2023, Israel’s largest life sciences conference.